Skip to content

Menu

ChannelsPublishersSubscribe
LexBlog, Inc. logo
LexBlog, Inc. logo
ProductsSub-MenuBlogsPortalsTwentySyndicationMicrositesResource Center
Join
Search
Close
Join the Movement. Blog 4 Good

Xeljanz and Other JAK Inhibitors: Drug Safety Concerns Indicated by Recent FDA Actions

April 15, 2021

Belviq Recall Aftermath: Further FDA Action in 2021 Means There Will Be No Generic Belviq Products

April 7, 2021

Possible Ramifications of Recent FDA Alert About Xeljanz Heart Problems and Xeljanz-related Cancers

March 23, 2021

Elmiron Drug Safety-related Labeling Changes for Pigmentary Maculopathy Side Effect

March 16, 2021

Beovu Vision Loss Lawsuits Involve Serious Eye Problems due to Beovu Injections Reactions

March 10, 2021

Past Elmiron Use Linked to Pigmentary Maculopathy and Vision Loss, Again, by Two Recent Medical Studies

February 24, 2021

Xeljanz Has A New Drug Safety Issue, We Just Don't Know How Significant It Is, Yet

February 17, 2021

Xeljanz FDA Drug Safety Communication in February 2021 Puts Heightened Scrutiny on Pfizer

February 11, 2021

Beovu Side Effects Have Caused Eye Doctors to Avoid Beovu and Use Other Safer AMD Drugs Instead

January 29, 2021

Elmiron Maculopathy Secondary to Pentosan Polysulfate (PPS) Toxicity: Medical Journal Article

January 25, 2021

Post navigation

Older Posts 
Blogs
  • Drug Injury Watch
Firm/Org
  • Law Offices of Thomas J. Lamb, P.A.

Tom Lamb

Blogs
  • Drug Injury Watch
Firm/Org
  • Law Offices of Thomas J. Lamb, P.A.

Stay Connected

Facebook LinkedIn Twitter RSS
Real Lawyers

Company

  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service

Products

  • Products
  • Blogs
  • Portals
  • Twenty
  • Syndication
  • Microsites

Support

  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • DSR Health Law Blog
  • Immigration View
  • Diving Deeper Into Work
  • North Carolina Appellate Practice Blog
  • Allens Insights
Copyright © 2021, LexBlog, Inc. All Rights Reserved.
Powered By LexBlog